Long-term management of panic disorder

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 5, 2004, Pages 24-28

  Doyle, Alicia ^a   Pollack, Mark H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; HUMAN; LONG TERM CARE; MULTIMODALITY CANCER THERAPY; PANIC; REVIEW;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR THERAPY; BENZODIAZEPINES; COMBINED MODALITY THERAPY; HUMANS; LONG-TERM CARE; PANIC DISORDER; SEROTONIN UPTAKE INHIBITORS;

EID: 3242721792     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Katschnig H, Amering M, Stolk JM, et al. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry 1995;167:487-494
2. Pollack M, Otto MW, Sabatino SA, et al. Predictors of time to relapse in a longitudinal study of panic disorder. Presented at the 33rd annual meeting of the American College of Neuropsychopharmacology; Dec. 11-14, 1994; San Juan, Puerto Rico
3. Keller MB, Yonkers KA, Warshaw MG, et al. Remission and relapse in subjects with panic disorder and panic with agoraphobia. J Nerv Ment Dis 1994;182:290-296
4. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-816
5. Herzog DB, Sacks NR, Keller MB, et al. Patterns and predictors of recovery in anorexia nervosa and bulimia nervosa. J Am Acad Child Adolesc Psychiatry 1993;32:835-842
6. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Panic Disorder. Am J Psychiatry 1998;155(suppl 5):1-34
7. Bruce SE, Vasile RG, Goisman RM. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 2003;160:1432-1438
8. Pollack MH, Simon NM, Worthington JJ, et al. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol 2003;17:276-282
9. Goddard AW, Brouette T, Almai A, et al. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001;58:681-686
10. Noyes R, Garvey MJ, Cook BL, et al. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. J Clin Psychiatry 1989;50:163-169
11. Nagy LM, Krystal JH, Charney DS, et al. Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment in panic disorder: 2.9 year naturalistic follow-up study. Arch Gen Psychiatry 1993;13:16-24
12. Burnham DB, Steiner MX, Gergel IP, et al. Paroxetine long-term safety and efficacy in panic disorder and the prevention of relapse: a double-blind study. Presented at the 34th annual meeting of the American College of Neuropsychopharmacology; Dec 11-14, 1995; San Juan, Puerto Rico
13. Rapaport MH, Wolkow R, Rubin A. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand 2001;104:289-298
14. Nagy LM, Krystal JH, Woods SW, et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder: 2.5 year naturalistic follow-up study. Arch Gen Psychiatry 1989;46:993-999
15. Pollack MH, Tesar GE, Rosenbaum JF, et al. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol 1986;6:302-304
16. Spier SA, Tesar GE, Rosenbaum JF, et al. Treatment of panic disorder and agoraphobia with clonazepam. J Clin Psychiatry 1986;47:238-242
17. Pollack MH, Otto MW, Tesar GE, et al. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol 1993;13:257-263
18. Tesar GE, Rosenbaum JF, Pollack MH, et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry 1991;52:69-76
19. Worthington JJ III, Pollack MH, Otto MW, et al. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull 1998;34:199-205
20. Mavissakalian MR, Perel JM. Duration of imipramine therapy and relapse in panic disorder with agoraphobia. J Clin Psychopharmacol 2002;22:294-299
21. Mavissakalian M, Perel JM. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. Am J Psychiatry 1992;149:1053-1057
22. Scott EL, Pollack MH, Otto MW. Clinician response to treatment refractory panic disorder: a survey of psychiatrists. J Nerv Ment Dis 1999;187:755-757
23. Brown TA, Barlow DH. Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995;63:754-765
24. Goisman RM, Warshaw MG, Keller MB. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia. Am J Psychiatry 1999;156:1819-1821
25. Pollack MH, Otto MW, Kaspi SP, et al. Cognitive-behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry 1994;55:200-205
26. Barlow DH, Gorman JM, Shear MK, et al. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-2536